BB Biotech AG
BION
Pozycja w akcjach
#4553
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Cena akcji
$60.31
Kapitalizacja rynkowa
$3.33B
Zmiana (1 dzień)
-1.39%
Zmiana (1 rok)
23.25%
Kraj
CH
Handel BB Biotech AG (BION)
Kategoria
Financial Services
Historia ceny akcji dla BB Biotech AG (BION)
Najwyższa cena zamknięcia: $63.76 dnia 2026-10-01
Najniższa cena zamknięcia: $15.30 dnia 2000-01-01
Najniższa cena zamknięcia: $15.30 dnia 2000-01-01
Historia cen akcji firmy BB Biotech AG od 2000 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 6.35% |
| 2025 | 38.69% |
| 2024 | -11.18% |
| 2023 | -24.95% |
| 2022 | -25.80% |
| 2021 | 2.69% |
| 2020 | 17.40% |
| 2019 | 11.01% |
| 2018 | -6.61% |
| 2017 | 23.80% |
| 2016 | -7.89% |
| 2015 | 22.59% |
| 2014 | 52.76% |
| 2013 | 62.77% |
| 2012 | 49.65% |
| 2011 | 1.37% |
| 2010 | -14.60% |
| 2009 | 29.73% |
| 2008 | -26.26% |
| 2007 | 3.29% |
| 2006 | 23.76% |
| 2005 | 1.84% |
| 2004 | 19.32% |
| 2003 | 21.32% |
| 2002 | -43.88% |
| 2001 | -30.37% |
| 2000 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $1.15K | 1.58% |
US
|
|
| $41.03 | 24.07% |
SE
|
|
| $109.74 | -32.14% |
US
|
|
| $89.85 | -27.13% |
US
|
|
| $46.03 | -14.74% |
US
|
